A detailed history of Thompson Siegel & Walmsley LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Thompson Siegel & Walmsley LLC holds 4,131 shares of AZN stock, worth $310,733. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,131
Previous 4,131 -0.0%
Holding current value
$310,733
Previous $280,000 15.0%
% of portfolio
0.01%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

SELL
$61.03 - $69.57 $30,820 - $35,132
-505 Reduced 10.89%
4,131 $280,000
Q4 2023

Feb 07, 2024

SELL
$61.89 - $69.28 $38,619 - $43,230
-624 Reduced 11.86%
4,636 $312,000
Q3 2023

Nov 08, 2023

SELL
$64.85 - $71.7 $5,836 - $6,453
-90 Reduced 1.68%
5,260 $356,000
Q2 2023

Aug 10, 2023

SELL
$69.91 - $75.81 $7,410 - $8,035
-106 Reduced 1.94%
5,350 $383,000
Q1 2023

May 11, 2023

SELL
$63.15 - $71.6 $3,031 - $3,436
-48 Reduced 0.87%
5,456 $379,000
Q4 2022

Feb 10, 2023

BUY
$54.21 - $70.44 $298,371 - $387,701
5,504 New
5,504 $373,000
Q3 2022

Oct 25, 2022

SELL
$53.02 - $135.75 $15,110 - $38,688
-285 Reduced 4.92%
5,504 $302,000
Q2 2022

Jul 22, 2022

SELL
$59.26 - $71.14 $444,450 - $533,550
-7,500 Reduced 56.44%
5,789 $382,000
Q1 2022

Apr 26, 2022

SELL
$55.72 - $67.12 $74,386 - $89,605
-1,335 Reduced 9.13%
13,289 $882,000
Q4 2021

Feb 09, 2022

SELL
$54.02 - $63.83 $82,812 - $97,851
-1,533 Reduced 9.49%
14,624 $852,000
Q3 2021

Nov 05, 2021

BUY
$55.56 - $60.79 $866,180 - $947,716
15,590 Added 2749.56%
16,157 $970,000
Q1 2021

May 07, 2021

SELL
$47.16 - $54.44 $17,024 - $19,652
-361 Reduced 38.9%
567 $28,000
Q3 2020

Nov 12, 2020

SELL
$53.07 - $61.1 $10,614 - $12,220
-200 Reduced 17.73%
928 $51,000
Q2 2019

Aug 12, 2019

SELL
$37.28 - $41.68 $8,648 - $9,669
-232 Reduced 17.06%
1,128 $47,000
Q3 2017

Nov 08, 2017

SELL
$28.96 - $34.0 $160,438 - $188,360
-5,540 Reduced 80.29%
1,360 $46,000
Q2 2017

Aug 09, 2017

BUY
N/A
6,900
6,900 $235,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $233B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Thompson Siegel & Walmsley LLC Portfolio

Follow Thompson Siegel & Walmsley LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thompson Siegel & Walmsley LLC, based on Form 13F filings with the SEC.

News

Stay updated on Thompson Siegel & Walmsley LLC with notifications on news.